An audit of baseline HIV-1 genotypic resistance testing in a UK provincial city
| Autor: | E F Monteiro, N R Armstrong, E J Street, A D Hale |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Sexually transmitted disease
Male medicine.medical_specialty Genotype Anti-HIV Agents Human immunodeficiency virus (HIV) HIV Infections Dermatology Audit medicine.disease_cause Acquired immunodeficiency syndrome (AIDS) Internal medicine Antiretroviral Therapy Highly Active Drug Resistance Viral Medicine Humans Pharmacology (medical) Baseline (configuration management) Sida biology business.industry Public Health Environmental and Occupational Health biology.organism_classification medicine.disease United Kingdom Infectious Diseases Treatment Outcome Immunology Genotypic resistance HIV-1 Female Viral disease business |
| Zdroj: | International journal of STDAIDS. 19(6) |
| ISSN: | 0956-4624 |
| Popis: | Summary: Baseline HIV-1 resistance testing is recommended in the 2005 BHIVA treatment guidelines. We compared the practice in our clinic with these guidelines. The aim of this study was to assess the prevalence of transmitted resistance in all antiretroviral therapy-naïve patients identified from our virology resistance test database. In 2006, 93% of all newly diagnosed patients had a baseline HIV-1 genotypic resistance test performed. The estimated prevalence of transmitted resistance was 8% in newly diagnosed patients and 7% overall with the majority in subtype B. These findings are in keeping with nationally reported data. It was of concern that we also identified a number of patients who had tested negative in the previous year. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|